Trifecta Pharma Co Ltd - Company Review
Trifecta Pharma Co Ltd - Company ReviewSummary
Trifecta Pharma Co Ltd (Trifecta Pharma) is a manufacturer and supplier of generic pharmaceuticals, nutraceuticals, and medical supplies. The company's medical supplies include medical instruments, medical dressing, medical latex and plastic, medical equipment, veterinary products and non-woven medical products. Its veterinary products comprise albendazole tablet, albendazole oral suspension, analgin injection and amprolium API, among others. Trifecta Pharma provides active pharmaceutical ingredients such as amlodipine besylate, amprolium, atracurium besylate, butorphanol, ceftriaxone sodium, cisatracurium besylate, dexmedetomidine, docetaxel, etoposide, florfenicol, gliclazide and ifosfamide, among others. The company operates in China and the US. Trifecta Pharma is headquartered in Shanghai, China.
This comprehensive company report of Trifecta Pharma Co Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.